Venetoclax–azacitidine as a bridge to transplant in pediatric relapsed/refractory acute myeloid leukemia: A real-world experience
Background: Survival outcomes in pediatric acute myeloid leukemia (AML) have improved significantly; however, prognosis for relapsed or refractory (R/R) disease remains dismal. This study evaluates real-world outcomes of Venetoclax-Azacytidine (Ven–Aza) as a bridge to transplant in children with R/R...
Збережено в:
| Автори: | , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2026-06-01
|
| Серія: | Pediatric Hematology Oncology Journal |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2468124526000355 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|